In a recent news article, Forbes Magazine discussed the benefits and drawbacks of alternative cancer medical treatments in the United States and abroad. Alternative, holistic medical treatments have always been available as a method of treatment for illnesses since the beginning of human interaction with treatments and relief aids. It has only been within the last hundred years of medical history that the mainstream medical community has shunned the use of natural remedies for the treatments of various diseases and suggested, instead, the use of treatments made of chemicals and objects foreign to the human body. Because the cancer industry is extremely profitable in most developed nations, small percentages of certain populations have begun to make a shift from traditional, pharmaceutical industry influenced medicine to a more natural approach to cancer treatment. Forbes contributor, David Chan, discussed the trend of alternative cancer treatments and its effects on the human body.
Chan’s discussion of the available natural treatments for cancer is not extensive, to say the least. The physician from the Stanford Department of Oncology simply reasons that the treatments do not work because the government systems in the United States, Canada, England, and France are not investing in the study of the holistic treatments. According to David Chan, this is reason enough to determine that holistic cancer treatments are not profitable to the removal of cancer cells in the human body.
Many holistic treatment professionals and physicians would argue with the Stanford physician’s simplistic view of natural healthcare treatments, however. Dr. Max Gearson, the developer of the Gearson Method for cancer treatment, for instance, spent decades attempting to popularize his effective treatment for cancer and was met with hostility for daring to present science that did not allow for the use of pharmaceutical drugs. Dr. Chan failed to discuss the fact that the pharmaceutical industry has a large presence in most major political systems.